Equator Therapeutics
Develops a drug to burn calories and improve metabolism.
Employees
Market cap
-
Enterprise valuation
CAD818k—1m (Dealroom.co estimates Mar 2020.)
San Francisco California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
$150k | Seed | ||
* | $500k | Early VC | |
| Total Funding | CAD886k | ||
Related Content
Recent News about Equator Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.